Regal Assets Analytics

VRNA

Verona (VRNA) Talks Up The Long View Following Phase II Setback

By |2019-03-07T14:59:36-05:00January 16th, 2019|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: , , , |

Verona Pharma (NASDAQ:VRNA) highlighted a surprising benefit from a lower [...]

Verona Pharma (VRNA) January 2019 Catalyst: Topline data for RPL554

By |2020-03-30T10:13:58-04:00January 8th, 2019|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

SUMMARY Sana Currents assigns a pivotal sentiment that Verona Pharma [...]